Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Effects of Short-term Adaptation to Ketogenic Diet on Endurance Trained Athletes

NCT07838818 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2024-11-01
Last updated
2026-09-29

Condition(s) studied

Ketogenic DietControl Condition

Investigational drug(s) / intervention(s)

Ketogenic dietControl Diet

Ketogenic diet: KD (5% CHO, 2.0 g/kg/day protein)

Control Diet: Control diet: 55% CHO, 2.0 g/kg/day protein

Study summary

Skeletal muscle glycogen is a major endogenous carbohydrate store and an important substrate for ATP resynthesis during exercise. Its utilization increases with exercise intensity and duration, and low muscle glycogen availability has long been associated with impaired endurance exercise capacity. Beyond its role as a metabolic substrate, glycogen availability may influence excitation-contraction coupling and Ca²⁺ handling, providing multiple mechanisms through which carbohydrate availability can affect contractile function and fatigue.

Ketogenic diets (KD), characterized by severe carbohydrate restriction (\<5% of energy intake), induce a profound redistribution of exercise metabolism. Reduced carbohydrate availability markedly increases fat oxidation while decreasing reliance on carbohydrate and muscle glycogen during exercise. This adaptation has frequently been interpreted as a glycogen-sparing mechanism that could extend endogenous carbohydrate availability during prolonged exercise. However, reduced glycogen utilization does not necessarily imply glycogen preservation, particularly when exercise begins with substantially lower muscle glycogen stores. Direct evidence quantifying muscle glycogen before and after a standardized exercise bout during ketogenic adaptation remains limited.

The marked shift toward lipid oxidation may also have consequences for exercise energetics. Fat oxidation provides less ATP per unit of oxygen consumed than carbohydrate oxidation, thereby increasing the oxygen requirement for a given rate of oxidative ATP resynthesis. This may become particularly relevant as exercise intensity and ATP demand increase, when carbohydrate-derived energy provision becomes progressively more important. Thus, ketogenic adaptation may reduce glycogen utilization while simultaneously increasing the oxygen cost of exercise and limiting the capacity to sustain higher exercise intensities. Nutritional ketosis may additionally influence exercise responses beyond skeletal muscle metabolism. KD markedly increases circulating β-hydroxybutyrate (βHB), which can be utilized as an oxidative substrate by peripheral tissues and crosses the blood-brain barrier, contributing to cerebral oxidative metabolism. Whether increased ketone availability modifies the cerebral response to exercise, and whether this relates to perceptual or exercise responses during carbohydrate restriction, remains unclear.

Accordingly, the specific aims are:

1. To determine the effects of 10 days of ketogenic adaptation on skeletal muscle glycogen availability and utilization during standardized prolonged exercise. It is hypothesized that KD reduces resting muscle glycogen and attenuates exercise-induced glycogen utilization without preserving post-exercise glycogen availability.
2. To determine the effects of ketogenic adaptation on substrate oxidation, exercise energetics, and exercise capacity. It is hypothesized that the shift toward greater lipid oxidation increases the oxygen cost of standardized submaximal exercise and impairs both prolonged exercise tolerance and subsequent high-intensity endurance capacity.
3. To explore circulating substrate, perceptual, and cerebral responses to exercise during nutritional ketosis. Glucose, lactate, and βHB responses, together with prefrontal cortical oxygenation assessed by functional near-infrared spectroscopy (fNIRS), are examined to determine whether the pronounced peripheral metabolic adaptations are accompanied by detectable alterations in cerebral hemodynamic or perceptual responses.

The main hypothesis is that short-term ketogenic adaptation induces a rapid shift from carbohydrate- toward lipid-derived energy provision, but that reduced glycogen utilization does not preserve absolute skeletal muscle glycogen availability. It is further hypothesized that this metabolic redistribution increases the oxygen requirement of prolonged exercise and impairs exercise capacity, particularly as energetic demand increases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Male * Age 18-40 yr, * BMI: 18-25 kg/m\^2, * At least two years of endurance training experience * a cycling volume of at least 150 km·week * habitual consumption of a carbohydrate-based diet (\>50% of total daily energy intake from carbohydrates) Exclusion Criteria: * Chronic diseases * Acute inflammatory states * Psychiatric disorders * Recent (within 3 months) treatment with anabolic steroids or systemic corticosteroids

Primary outcome measure(s)

  • Skeletal muscle glycogen — 10 days
    Resting Skeletal muscle glycogen and skeletal muscle utilization during exercise
  • Endurance performance — 10 days
    Overall exercise tolerance will be quantified as total exercise duration (min), defined as the combined duration of the 2-h submaximal exercise bout and the subsequent TTE. Subsequent high-intensity endurance capacity will be quantified separately as TTE duration (min) .
  • Pre-frontal cortex hemodynamics and perceived fatigability during endurance exercise — 10 days
    Functional near-infrared spectroscopy (fNIRS) was used to evaluate prefrontal cortex hemodynamics during exercise + questionnaire ( ROF, Feeiling scale)

Trial sites (1)

FacilityCityRegionStatus
Department of Biomedical Sciences, University of Padus Padova Italy
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07838818 on ClinicalTrials.gov ↗ ← All trials in Italy